Detalles de la búsqueda
1.
Dried Blood Spot Sampling in the Monitoring of Anticancer Therapy for Solid Tumors: A Systematic Review.
Ther Drug Monit
; 45(3): 293-305, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750444
2.
Stakeholder perspectives on the impact of COVID-19 on oncology services: a qualitative study.
Support Care Cancer
; 31(8): 491, 2023 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488459
3.
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Int J Gynecol Cancer
; 32(4): 560-565, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551895
4.
Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines.
BMC Cancer
; 21(1): 1036, 2021 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34530765
5.
Acceptability and appropriateness of a clinical pathway for managing anxiety and depression in cancer patients: a mixed methods study of staff perspectives.
BMC Health Serv Res
; 21(1): 1243, 2021 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789239
6.
Promising Anticancer Activity of [Bis(1,8-quinolato)palladium (II)] Alone and in Combination.
Int J Mol Sci
; 22(16)2021 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34445176
7.
Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.
Int J Mol Sci
; 21(20)2020 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053689
8.
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Gynecol Oncol
; 154(3): 531-538, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227223
9.
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecol Oncol
; 152(1): 53-60, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30449719
10.
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Gynecol Oncol
; 154(1): 29-37, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31130288
11.
Pharmacokinetics of Anticancer Drugs Used in Treatment of Older Adults With Colorectal Cancer: A Systematic Review.
Ther Drug Monit
; 41(5): 553-560, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31584925
12.
Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial.
BMC Cancer
; 18(1): 1077, 2018 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30404619
13.
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.
Int J Gynecol Cancer
; 33(4): 628-630, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914169
14.
Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.
Int J Gynecol Cancer
; 27(5): 900-906, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28498256
15.
Changes in the in vitro activity of platinum drugs when administered in two aliquots.
BMC Cancer
; 16: 688, 2016 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566066
16.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Lancet Oncol
; 16(8): 928-36, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26115797
17.
The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study.
Support Care Cancer
; 23(2): 385-91, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25112562
18.
A phase 3 trial of bevacizumab in ovarian cancer.
N Engl J Med
; 365(26): 2484-96, 2011 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22204725
19.
Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres.
J Biomed Sci
; 21: 41, 2014 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24884683
20.
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Int J Gynecol Cancer
; 24(9 Suppl 3): S55-60, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25341582